News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Neurogen Corporation Announces 2007 Financial Results
March 17, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, today announced financial results for the year and quarter ended December 31, 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
C-suite
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
September 14, 2026
·
3 min read
·
Annalee Armstrong
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
·
2 min read
·
Nick Paul Taylor
Venture capital
Frazier adds $1.1B+ to small and mid-sized biotech fund
September 11, 2026
·
2 min read
·
Tristan Manalac
Business
Takeda’s long-term R&D head announces exit after major pipeline reorganization
September 10, 2026
·
2 min read
·
Gabrielle Masson
